Clover Health Investments, Corp. Warrants
CLOVW
CLOVW was delisted on the 23rd of August, 2021.
17 hedge funds and large institutions have $29.1M invested in Clover Health Investments, Corp. Warrants in 2020 Q2 according to their latest regulatory filings, with 17 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LA
Linden Advisors
New York
|
+$8.38M |
| 2 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$5.57M |
| 3 |
LCM
LH Capital Markets
New York
|
+$3.48M |
| 4 |
SCM
Suvretta Capital Management
New York
|
+$2.35M |
| 5 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
+$2.14M |
Top Sellers
CLOVW Hedge Fund Activity: Q2 2020 in Review
17 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Clover Health Investments, Corp. Warrants (CLOVW) for Q2 2020, worth a combined $29.1M.
Buyers outnumbered sellers: 17 funds opened new CLOVW positions and 0 closed out — a net gain of 17 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Linden Advisors, opening a new position worth an estimated $8.38M.
- 17 institutional investors held Clover Health Investments, Corp. Warrants (CLOVW) as of Q2 2020, up from 0 in Q1 2020.
- Funds reported $29.1M of Clover Health Investments, Corp. Warrants stock for Q2 2020.
- 17 funds opened new Clover Health Investments, Corp. Warrants positions in Q2 2020 and 0 closed out, a net change of +17 holders.
- The largest Clover Health Investments, Corp. Warrants buyer in Q2 2020 was Linden Advisors, an estimated $8.38M added.
Based on aggregated 13F filings for Q2 2020.